Parenteral drug products should be visually inspected for particulate matter and discoloration prior to administration, whenever the solution and container permit
Each ampoule is individually sealed to ensure maximum sterility and protection against contamination, making it a convenient and safe option for single-patient or single-use procedures
If for any reason, the physician does not approve, you will be instantly refunded
Current Pharmaceutical Design, 29(9), 692-715
The following is taken from the section, "How should treatment be given", from the peer-reviewed medical-journal article, "The Many Faces of Cobalamin (Vitamin B12) Deficiency": [Start quote] For parenteral therapy in cases of megaloblastic anemia, it has been advised to administer 1000 mg hydroxocobalamin IM twice weekly for a period of 5 weeks, and the dose is reduced to 1000 mg IM every 2 months thereafter